Summary: DIAG723 adds new PAH presentation

Why It Matters: This shows new research data for their drug candidate. It highlights progress in a key disease area.

What Changed:

  • A new news item was added: "Presentation ALK1: BMPRII receptor clustering by an agonist bispecific antibody (rDIAG723) prevents PAH development in the rat SuHx model October 6, 2025 READ MORE"
  • Contact information was added at the bottom of the page, including general, media, and clinical trial emails, and a physical address.
Track companies like diagonaltx.com
Get actionable insights on price changes, product launches, positioning shifts and more
Start Tracking →